Citation: A. Sharma et al., ESTIMATION OF ORAL BIOAVAILABILITY OF A LONG HALF-LIFE DRUG IN HEALTHY-SUBJECTS, Pharmaceutical research, 15(11), 1998, pp. 1782-1786
Authors:
MARINO MR
LANGENBACHER KM
HAMMETT JL
NICHOLA P
UDERMAN HD
Citation: Mr. Marino et al., THE EFFECT OF NEFAZODONE ON THE SINGLE-DOSE PHARMACOKINETICS OF PHENYTOIN IN HEALTHY MALE-SUBJECTS, Journal of clinical psychopharmacology, 17(1), 1997, pp. 27-33
Authors:
HESTER TR
FORD NF
GALE PJ
HAMMETT JL
RAYMOND R
TURNBULL D
FRANKOS VH
COHEN MB
Citation: Tr. Hester et al., MEASUREMENT OF 2,4-TOLUENEDIAMINE IN URINE AND SERUM SAMPLES FROM WOMEN WITH MEME OR REPLICON BREAST IMPLANTS, Plastic and reconstructive surgery, 100(5), 1997, pp. 1291-1298
Authors:
GEHR TWB
SICA DA
SLUGG PH
HAMMETT JL
RAYMOND R
FORD NF
Citation: Twb. Gehr et al., THE PHARMACOKINETICS OF PRAVASTATIN IN PATIENTS ON CHRONIC-HEMODIALYSIS, European Journal of Clinical Pharmacology, 53(2), 1997, pp. 117-121
Authors:
SICA DA
MARINO MR
HAMMETT JL
FERREIRA I
GEHR TWB
FORD NF
Citation: Da. Sica et al., THE PHARMACOKINETICS OF IRBESARTAN IN RENAL-FAILURE AND MAINTENANCE HEMODIALYSIS, Clinical pharmacology and therapeutics, 62(6), 1997, pp. 610-618
Authors:
FORD NF
LASSETER KC
VANHARKEN DR
HAMMETT JL
RAYMOND R
MANNING J
Citation: Nf. Ford et al., SINGLE-DOSE AND STEADY-STATE PHARMACOKINETICS OF FOSINOPRIL AND FOSINOPRILAT IN PATIENTS WITH HEPATIC IMPAIRMENT, Journal of clinical pharmacology, 35(2), 1995, pp. 145-150